Zealand Pharma A/s(FRA) 22Z

Market Cap€2.92B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€40.29

-6.24%

-2.68Today

Zealand Pharma A/s Financials at a Glance

Market Cap

€2.92B

Revenue (TTM)

€621.36

Net Income (TTM)

€366.47

EPS (TTM)

€5.17

P/E Ratio

8.08

Dividend

€0.00

Beta (Volatility)

-0.06 (Low)

Dividend

€0.00

Beta (Volatility)

-0.06 (Low)

Price

€40.29

Volume

612

Open

€41.35

Price

€40.29

Volume

612

Open

€41.35

Previous Close

€40.29

Daily Range

€40.29 - €41.35

52-Week Range

€31.50 - €73.80

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.06 (Low)

Price

€40.29

Volume

612

Open

€41.35

Previous Close

€40.29

Daily Range

€40.29 - €41.35

52-Week Range

€31.50 - €73.80

Estimated Earnings Date

N/A

22Z News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zealand Pharma A/s

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.

Industry

Biotechnology

Sector

Health Care

Employees

578

CEO

Adam Sinding Steensberg, MD, MBA

Website

www.zealandpharma.com

22Z Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

16.29%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

12.38%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.92B

Shares Outstanding

69.39M

Volume

612

Avg. Volume

48.742

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Zealand Pharma A/s Performance Analysis

Zealand Pharma A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 13,977,698	-4.2%
2023	2023-12-31	EUR 46,005,623	229.1%
2024	2024-12-31	EUR 8,405,002	-81.7%
2025	2025-12-31	EUR 1,234,691,054	14590.0%

Zealand Pharma A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -2.81	18.6%
2023	2023-12-31	EUR -1.67	-40.6%
2024	2024-12-31	EUR -2.18	30.4%
2025	2025-12-31	EUR 12.09	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€600.94

+0.5%

Gross Profit

€599.47

+0.5%

Gross Margin

99.76%

+1.0%

Market Cap

€2.92B

N/A

Market Cap/Employee

€4.57

+0.6%

Employees

578

+1.4%

Net Income

€524.13

+0.5%

EBITDA

€517.84

+0.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€595.19

-41.9%

Total Debt

€54.98

+1.0%

Accounts Receivable

€510.51

+11.7%

Inventory

€0.00

+0.0%

Long Term Debt

€51.10

+1.0%

Short Term Debt

€3.88

+1.7%

Return on Assets

14.82%

+0.3%

Return on Invested Capital

-25.66%

+0.5%

Free Cash Flow

€52.62

+0.0%

Operating Cash Flow

€54.36

+0.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About 22Z

What is the current price of Zealand Pharma A/s?

Zealand Pharma A/s is trading at €40.29 per share.

What is the 52-week range for Zealand Pharma A/s?

Over the past 52 weeks, Zealand Pharma A/s has traded between €31.50 and €73.80.

How much debt does Zealand Pharma A/s have?

As of the most recent reporting period, Zealand Pharma A/s reported total debt of €54.98M.

How much cash does Zealand Pharma A/s have on hand?

Zealand Pharma A/s reported €540.21M in cash and cash equivalents in its most recent financial results.

What is Zealand Pharma A/s’s dividend yield?

Zealand Pharma A/s does not currently have a dividend yield.

Zealand Pharma A/s(FRA) 22Z

Zealand Pharma A/s Financials at a Glance

22Z News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Zealand Pharma A/s

22Z Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Zealand Pharma A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 22Z

What is the current price of Zealand Pharma A/s?

What is the 52-week range for Zealand Pharma A/s?

How much debt does Zealand Pharma A/s have?

How much cash does Zealand Pharma A/s have on hand?

What is Zealand Pharma A/s’s dividend yield?

Premium Investing Services